Saturday 17 October 2026
Export ETAOF’s income statement to Excel — free account
ETAO International Co., Ltd.
ETAOF Healthcare Health Information Services
ETAO International Co., Ltd.’s revenue for fiscal 2022 (year ended December 2022) was $58.1 million. Operating cash flow growth for five consecutive years.
0.00
0.00
NaN
Follow ETAOF
ETAO International Co., Ltd. (ETAOF) P/E ratio
ETAO International Co., Ltd. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ETAOF ETAO International Co., Ltd. | n/m |
| MGRX Mangoceuticals, Inc. compare | n/m |
| ACON Aclarion, Inc. compare | n/m |
| BFRG Bullfrog AI Holdings Inc. compare | n/m |
| ZCMD Zhongchao Inc. compare | n/m |
| RNLXY Renalytix plc - Sponsored ADR compare | n/m |
| HLTHQ Cue Health Inc. compare | n/m |
| BEAT HeartBeam, Inc. compare | n/m |
| HCTI Healthcare Triangle, Inc. compare | 0.0× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)